This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 2 CIPO patents and 1 EPO patent. Top assignees: Bristol-Myers Squibb & Gilead Sciences, Inc., Gilead Sciences, Inc.. Active years: 2013-2017.
Location History:
- Saratoga, CA (US) (2013 - 2015)
- Monte Sereno, CA (US) (2014 - 2017)
Company Filing History:

Years Active: 2013-2017
Title: The Innovations of Taiyin Yang
Introduction
Taiyin Yang is a notable inventor based in Monte Sereno, CA (US). He has made significant contributions to the pharmaceutical industry, holding a total of 4 patents. His work focuses on developing innovative pharmaceutical products that enhance treatment options for patients.
Latest Patents
Among his latest patents is a novel pharmaceutical dosage form that combines efavirenz, emtricitabine, and tenofovir DF. This multicomponent unitary oral dosage form features a stabilizing configuration, with component 1 comprising tenofovir DF and, optionally, emtricitabine, while component 2 consists of efavirenz. In preferred embodiments, component 1 is produced through dry granulation, showcasing Yang's commitment to improving pharmaceutical formulations.
Career Highlights
Taiyin Yang has worked with prominent companies in the pharmaceutical sector, including Bristol-Myers Squibb and Gilead Sciences, Inc. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking innovations in drug development.
Collaborations
Throughout his career, Yang has collaborated with esteemed colleagues such as Terrence C Dahl and Mark Michael Menning. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in pharmaceutical research.
Conclusion
Taiyin Yang's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to impact the industry positively, paving the way for future advancements in drug formulation and delivery.